Buy Aster DM Healthcare; target of Rs 210: ICICI Direct

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

ICICI Direct's research report on Aster DM Healthcare

Q3 revenues stayed flat QoQ at Rs 2259 crore (still down 2.7% YoY) vs. Rs 2268 crore in the last quarter. India revenues grew 10.8% QoQ (up 6.7% YoY) to Rs 460 crore. However, GCC revenues de-grew 3.4% QoQ (down 4.6% YoY) to Rs 1866 crore. EBITDA margins expanded 257 bps QoQ to 14.5% due to lower other expenditure. Subsequent EBITDA grew 21.0% QoQ to Rs 328 crore. PAT came in at Rs 92 crore, which is ~2.8x of last quarter.

Outlook

We envisage favourable risk-reward matrix and maintain BUY rating with a target price of Rs 210 on SOTP basis (vs. earlier Rs 170).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More